Insider Transactions in Q4 2024 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
15
-0.06%
|
$7,170
$478.56 P/Share
|
|
Nov 11
2024
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-6.36%
|
$1,554,000
$518.27 P/Share
|
|
Nov 08
2024
|
Reshma Kewalramani CEO & President |
SELL
Open market or private sale
|
Direct |
15,198
-16.71%
|
$7,826,970
$515.0 P/Share
|
|
Oct 02
2024
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
999
-5.66%
|
$460,539
$461.66 P/Share
|
|
Oct 01
2024
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
630
-3.45%
|
$293,580
$466.84 P/Share
|